Literature DB >> 2975225

Blockade of potentiated startle responding in rats by 5-hydroxytryptamine1A receptor ligands.

R S Mansbach1, M A Geyer.   

Abstract

A potentiated whole-body startle response was produced in rats by pairing intense acoustic stimuli with a light (conditional stimulus) formerly presented contiguously with electric shock. Administration of the selective serotonin (5-HT) 1A ligand 8-hydroxy-2-(di-n-propylamino)tetralin (0.125 and 0.5 mg/kg) blocked the potentiation of startle induced by the conditional stimulus. 1-[3-Chlorophenyl]piperazine, a non-anxiolytic 5-HT1B/1C agonist, did not block potentiated startle, even at a dose (1.0 mg/kg) that induced significant overall decreases in startle amplitude. The non-benzodiazepine anxiolytics buspirone (1.25-5.0 mg/kg), gepirone (3.0-10.0 mg/kg) and the related 5-HT1A ligand ipsapirone (1.0-10.0 mg/kg) blocked potentiated startle, though effects of the non-selective serotonin antagonist methysergide (0.3-10.0 mg/kg) fell short of significance. These data support a role for the 5-HT1A binding site in the anti-anxiety effects of buspirone and related compounds over a range of behavioral procedures.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2975225     DOI: 10.1016/0014-2999(88)90283-x

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  21 in total

1.  The brain orexin system and almorexant in fear-conditioned startle reactions in the rat.

Authors:  Michel A Steiner; Hugues Lecourt; Francois Jenck
Journal:  Psychopharmacology (Berl)       Date:  2012-05-17       Impact factor: 4.530

2.  Lesions of the habenula produce stress- and dopamine-dependent alterations in prepulse inhibition and locomotion.

Authors:  Scott A Heldt; Kerry J Ressler
Journal:  Brain Res       Date:  2006-01-24       Impact factor: 3.252

Review 3.  Role of corticotropin releasing factor in anxiety disorders: a translational research perspective.

Authors:  Victoria B Risbrough; Murray B Stein
Journal:  Horm Behav       Date:  2006-07-25       Impact factor: 3.587

4.  The GABA(B) receptor positive modulator BHF177 attenuated anxiety, but not conditioned fear, in rats.

Authors:  Xia Li; Katarzyna Kaczanowska; M G Finn; Athina Markou; Victoria B Risbrough
Journal:  Neuropharmacology       Date:  2015-05-19       Impact factor: 5.250

5.  Delayed procedural learning in α7-nicotinic acetylcholine receptor knockout mice.

Authors:  J W Young; J M Meves; I S Tarantino; S Caldwell; M A Geyer
Journal:  Genes Brain Behav       Date:  2011-07-07       Impact factor: 3.449

6.  Role of corticotropin releasing factor (CRF) receptors 1 and 2 in CRF-potentiated acoustic startle in mice.

Authors:  Victoria B Risbrough; Richard L Hauger; Mary Ann Pelleymounter; Mark A Geyer
Journal:  Psychopharmacology (Berl)       Date:  2003-07-04       Impact factor: 4.530

7.  Fear-potentiated startle response is remarkably similar in two laboratories.

Authors:  R J Joordens; T H Hijzen; B W Peeters; B Olivier
Journal:  Psychopharmacology (Berl)       Date:  1996-07       Impact factor: 4.530

Review 8.  Phasic vs sustained fear in rats and humans: role of the extended amygdala in fear vs anxiety.

Authors:  Michael Davis; David L Walker; Leigh Miles; Christian Grillon
Journal:  Neuropsychopharmacology       Date:  2010-01       Impact factor: 7.853

9.  Double dissociation between the involvement of the bed nucleus of the stria terminalis and the central nucleus of the amygdala in startle increases produced by conditioned versus unconditioned fear.

Authors:  D L Walker; M Davis
Journal:  J Neurosci       Date:  1997-12-01       Impact factor: 6.167

10.  The neurotensin-1 receptor agonist PD149163 blocks fear-potentiated startle.

Authors:  Paul D Shilling; David Feifel
Journal:  Pharmacol Biochem Behav       Date:  2008-10       Impact factor: 3.533

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.